This year’s #SEED2025 program is one of our most dynamic yet packed with visionary speakers, cutting-edge sessions, and the latest in synthetic biology innovation. Explore the full technical lineup and register now: bit.ly/4fOZQG1 #syntheticbiology #research #biotech

The tumor microenvironment’s role in the response to immune checkpoint blockade ⁦Nature Cancer⁩ nature.com/articles/s4301…

Phage DNA modifications evade defense: Phage DNA modification adds arabinose to cytosines via hydroxy linkage(5ara-hC) w/potential double & triple arabinosylation. Arabinosylated phages are protected from DNA-targeting CRISPR-Cas & restriction modification cell.com/cell-host-micr…

🔹Intratumoral Fusobacterium nucleatum is associated with better cancer-specific survival in head and neck cancer patients, by #JOM 🔸tandfonline.com/doi/full/10.10… #MAXILOLAPAZ

Review Nature Rev Immunol George Coukos Tumor-associated vasculature in T cell homing and immunity: opportunities for cancer therapy nature.com/articles/s4157…

📢 MorphLink is out now in Nature Communications! A framework designed to systematically identify disease-related morphological–molecular interplays. Congrats to Jian Hu Emory University and the team MD Anderson Cancer Center. nature.com/articles/s4146…

Looking forward to attending and presenting at #ENDO2025 next weekend in SF and also hearing about exciting work from Katherine L. Cook, Dipali Sharma labs (SY16 - Diet, Gut, Microbiome, and Cancer).

Thrilled to see our work led by yunhe liu published in Cancer Cell featured by Nature Custom Media nature nature.com/articles/d4247… Huge thanks to Ian Le Guillou for the thoughtful interview, beautifully written piece Aubrey Bloom Clayton Boldt, Ph.D. MD Anderson Cancer Center for their support

Scientists at AFI, including Jessica Mark Welch, Ph.D., Tsute “George” Chen, Ph.D., Susan Weir, Ph.D., Susan Yost, and Tina Yaskell, along with external collaborators, have recently completed an update to the Human Oral Microbiome Database. Learn more: forsyth.org/ada-forsyth-an…

📈 The global rise of early-onset (<50) GI cancers is alarming — and accelerating. 🧬 In a new review, researchers highlight key trends across colorectal, gastric, pancreatic, and rare GI cancers: 🔍 Key Findings: • 📊 Incidence rising across EO GI cancers • 🧑🏽‍🤝‍🧑🏿

Hats off to Regina Barragan-Carrillo who (w Zeynep Zengin Yale Internal Medicine) put together a beautiful overview of #microbiome modulation for the treatment of #solidtumors in Journal of Clinical Oncology. Citing work from innovative #scientists & #trialists in the field like #Routy, #ElKrief, lisaderosa, #Zitvogel,

MD Anderson researchers combined immunotherapy with a non-toxic bacteria species that can trigger an antitumor response. Read how patients with treatment-refractory solid tumors responded: spr.ly/601847IK6 #EndCancer

Proud to share Jose M. Adrover’s (new PI The Francis Crick Institute) paper: As a postdoc (Cold Spring Harbor Laboratory/Johns Hopkins Medicine), he found #NETs in necrotic tumors—I shrugged. But he looked closer: NETs block tumor vessel perfusion, causing necrosis, hypoxia, EMT & #Metastasis. nature.com/articles/s4158… @JHU_BDP nature